Next Article in Journal
Clinical Efficacy of Sitafloxacin–Colistin–Meropenem and Colistin–Meropenem in Patients with Carbapenem-Resistant and Multidrug-Resistant Acinetobacter baumannii Hospital-Acquired Pneumonia (HAP)/Ventilator-Associated Pneumonia (VAP) in One Super-Tertiary Hospital in Bangkok, Thailand: A Randomized Controlled Trial
Next Article in Special Issue
Exploring the Molecular Mechanisms of Macrolide Resistance in Laboratory Mutant Helicobacter pylori
Previous Article in Journal
In Vitro Antibacterial Activity of Microbial Natural Products against Bacterial Pathogens of Veterinary and Zoonotic Relevance
 
 
Review
Peer-Review Record

Sequential versus Standard Triple Therapy for First-Line Helicobacter pylori Eradication: An Update

Antibiotics 2024, 13(2), 136; https://doi.org/10.3390/antibiotics13020136
by Olga P. Nyssen 1,*, Belén Martínez 1, Francis Mégraud 2, Vincenzo Savarino 3, Carlo A. Fallone 4, Franco Bazzoli 5 and Javier P. Gisbert 1,*
Reviewer 1: Anonymous
Reviewer 2:
Reviewer 3:
Antibiotics 2024, 13(2), 136; https://doi.org/10.3390/antibiotics13020136
Submission received: 14 December 2023 / Revised: 18 January 2024 / Accepted: 19 January 2024 / Published: 30 January 2024

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

please see the attached file.

Comments for author File: Comments.pdf

Comments on the Quality of English Language

nil

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Reviewer 2 Report

Comments and Suggestions for Authors

attached

Comments for author File: Comments.pdf

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Reviewer 3 Report

Comments and Suggestions for Authors


Comments for author File: Comments.pdf

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Back to TopTop